Methods for treating diseases related to the wnt pathway
Abstract
The present invention relates to methods for treating a disease, in which the disease arises from dysregulation of the Wnt signaling pathway. In some instances, the disease can be treated by administering a Wnt pathway inhibitory compound. In other instances, the method optionally includes conducting a genome-wide screening to determine one or more genes resulting in a reduced disease state and then identifying the gene(s) as being involved in the Wnt signaling pathway.
- Inventors:
- Issue Date:
- Research Org.:
- Sandia National Lab. (SNL-CA), Livermore, CA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1650782
- Patent Number(s):
- 10624949
- Application Number:
- 15/204,804
- Assignee:
- National Technology & Engineering Solutions of Sandia, LLC (Albuquerque, NM)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
- DOE Contract Number:
- AC04-94AL85000
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 07/07/2016
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Negrete, Oscar A., and Harmon, Brooke Nicole. Methods for treating diseases related to the wnt pathway. United States: N. p., 2020.
Web.
Negrete, Oscar A., & Harmon, Brooke Nicole. Methods for treating diseases related to the wnt pathway. United States.
Negrete, Oscar A., and Harmon, Brooke Nicole. Tue .
"Methods for treating diseases related to the wnt pathway". United States. https://www.osti.gov/servlets/purl/1650782.
@article{osti_1650782,
title = {Methods for treating diseases related to the wnt pathway},
author = {Negrete, Oscar A. and Harmon, Brooke Nicole},
abstractNote = {The present invention relates to methods for treating a disease, in which the disease arises from dysregulation of the Wnt signaling pathway. In some instances, the disease can be treated by administering a Wnt pathway inhibitory compound. In other instances, the method optionally includes conducting a genome-wide screening to determine one or more genes resulting in a reduced disease state and then identifying the gene(s) as being involved in the Wnt signaling pathway.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2020},
month = {4}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Compounds that Modulate Negative-Sense, Single-Stranded RNA Virus Replication and Uses Thereof
patent-application, May 2011
- Shaw, Megan L.; Hoffmann, Hans-Heinrich; Garcia-Sastre, Adolfo
- US Patent Application 12/921077; 20110105423
Selection and Characterization of Novel Plant-Derived Recombinant Human Interferons with Broad Spectrum Activity
patent-application, November 2012
- Padgett, Hal S.; Vojdani, Fakhrich S.; Vaewhogs, Andrew Am
- US Patent Application 13/478330; 20120302733
Triazole Derivatives as Wnt Signaling Pathway Inhibitors
patent-application, January 2014
- Holsworth, Daniel; Waaler, Jo; Machon, Ondrej
- US Patent Application 13/992879; 20140031374
Porous Nanoparticle-Supported Lipid Bilayers (Protocells) for Targeted Delivery Including Transdermal Delivery of Cargo and Methods thereof
patent-application, October 2015
- Ashley, Carlee Erin; Brinker, C. Jeffrey; Carnes, Eric C.
- US Patent Application 14/350674; 20150272885
Compositions and Methods for Potentiation of Cancer Agents
patent-application, August 2012
- Siede, Wolfram; Roque, Rouel S.
- US Patent Application 13/439386; 20120207857
Microelectroporation device for genomic screening
patent, September 2014
- Perroud, Thomas D.; Renzi, Ronald F.; Negrete, Oscar
- US Patent Document 8,828,736
WNT Protein Signaling Inhibitors
patent-application, February 2014
- Lum, Lawrence; Roth, Michael G.; Chen, Baozhi
- US Patent Application 13/875170; 20140038922
WNT Protein Signaling Inhibitors
patent-application, December 2015
- Lum, Lawrence; Roth, Michael G>; Chen, Baozhi
- US Patent Application 14/728105; 20150374696
Interaction Inhibitors of TCF-4 with Beta-Catenin
patent-application, October 2004
- Moll, Juergen; Knapp, Stefan; Daivit, Claudio
- US Patent Application 10/482755; 20040204477
Wnt Protein Signalling Inhibitors
patent-application, June 2015
- Lum, Lawrence; Roth, Michael; Chen, Baozhi
- US Patent Application 14/400001; 20150157633
WNT Pathway Inhibitors for Treating Viral Infections
patent-application, September 2014
- Silvestri, Guido; Chahroudi, Ann M.; Lichterfeld, Mathias
- US Patent Application 14/202459; 20140255426
Substituted 1H-Indazol-1-Ol Analogs as Inhibitors of Beta Catenin/TcF Protein-Protein Interactions
patent-application, January 2015
- Ji, Haitao; Yu, Binxun; Zhang, Min
- US Patent Application 14/377839; 20150025114
Antiviral Axin Stabilizer
patent-application, March 2017
- Liu, Lin; Guo, Yujie
- US Patent Application 15/123030; 20170065587
Triazole Derivatives as Wnt Signaling Pathway Inhibitors
patent-application, November 2015
- Holsworth, Daniel; Waaler, Jo; Machon, Ondrej
- US Patent Application 14/753537; 20150322057
N-(Hetero)Aryl, 2-(Hetero)Aryl-Substituted Acetamides for Use as Wnt Signaling Modulators
patent-application, March 2016
- Cheng, Dai; Gao, Wenqi; Han, Dong
- US Patent Application 14/962432; 20160082014